Biological News: Breaking Biological News, Comments and Articles.

Perosphere Receives FDA IND Clearance to Initiate Clinical Investigations of the Safety and Efficacy of PER977 to Reverse the Activity of Anticoagulation Therapies including Factor Xa- and IIa-Inhibitors

Clearance also includes Clinical Investigation of PER977 to Reverse the Anticoagulation Activity of Unfractionated Heparin, Low Molecular Weight Heparins, and Fondaparinux Perosphere Inc. announced today that it has received U.S. Food and Drug Administration ("FDA") Investigational New Drug ("IND") clearance to initiate clinical investigations of the s...

Mari's to Offer New Treatment from Europe

Mari's Skin Care is the first to offer Meta Therapy in the state of Texas. Dallas, TX (PRWEB) May 22, 2013 Mari’s Skin Care, a peaceful sanctuary for skin rejuvenation and nourishment in Dallas, has become the first in the state of Texas to offer a new treatment from Europe. The treatment is called Meta Therapy- Medical and Esthetic Tissue Activation, also known as collagen induction therap...

ImmunoCellular Therapeutics to Present at Marcum MicroCap Conference on May 30th

ImmunoCellular Therapeutics, Ltd. (“ImmunoCellular”) (NYSE MKT: IMUC) today announced that Andrew Gengos, Chief Executive Officer of ImmunoCellular, will present a corporate overview and business update at the Marcum MicroCap Conference on Thursday, May 30, 2013 at 9:00 am ET at the Grand Hyatt hotel, New York, New York. To access the live aud...

New molecular probes that shed light on biological systems

Reactive sulfur species have attracted increasing attention in biomedical research because of their involvement in a variety of physiological functions. There has been a rising interest in sulfane sulfur compounds – compounds which contain sulfur a...

ABPI to represent vaccine industry

ABPI to represent vaccine industry

iBio Technology Produces Vaccine Candidate for Recently Emerged H7N9 Influenza

NEWARK, Del., May 22, 2013 /PRNewswire/ -- PRNewswire – iBio, Inc. (NYSE MKT: IBIO) today announced the production of a vaccine candidate for the newly emerged H7N9 influenza virus by an independent third party laboratory using the iBioLaunch™ platform. This validation milestone was achieved in 21 days as measured from initial antigen sequence information to purification of recombinant...

Soligenix Announces Issuance of US Patent for its ThermoVax™ Technology

PRINCETON, N.J., May 22, 2013 /PRNewswire/ -- Soligenix, Inc. (OTCQB: SNGX) (Soligenix or the Company), a clinical stage biopharmaceutical company focused on developing products to treat inflammatory diseases and biodefense countermeasures where there remains an unmet medical need, announced today that the US Patent and Trademark Office granted patent 8,444,991 entitled "Method of Preparing a...

TransactRx Releases Part 3 of Series – Adult Vaccine Billing for Physicians Offices

Confusion around the process for adult vaccine billing for physicians has been routinely identified as one of the material impediments for the growth of vaccination programs. Coral Gables, FL (PRWEB) May 22, 2013 TransactRx, the nation’s leading Medicare Part D Vaccine Physician Billing System, announced today that it has released Part 3 – Adult Vaccine Billing for Physicians Offices of its 5...

BluePromoCode Offers Attractive Savings on Skin Care Solutions

Beauty and skin care retailers are traditionally resilient to economic cycles, given consumers' desire to look young. BluePromoCode provides promotions from prominent skin care product sites. Los Angeles, CA (PRWEB) May 22, 2013 BluePromoCode announced today its latest and most comprehensive selection of special promotions and discounts from skin care and beauty websites. Manufacturers of bea...

New York University Acquires 100th Leica Confocal Laser Scanning Microscope with White Light Laser for Morphogenetic Studies

The Leica TCS SP8 X provides total freedom of excitation and emission coupled with low laser power and high sensitivity The Department of Biology at New York University has been equipped with the 100th Leica TCS SP8 X, a state-of-the-art confocal laser scanning  microscope with a  white light laser. The system offers complete spectral freedom for fluorescence experiments. For live cell i...

UK-Norwegian collaboration aims to develop a new living skin equivalent testing model for testing inflammatory responses.

Epistem, the UK biotechnology and personalized medicine company with expertise in skin biology and delivery of dermatological testing services, and ScandiDerma, a Norwegian company with expertise in developing new dermatological ingredients from biom...

QuantuMDx and Genome Institue of Singapore announce collaboration to develop Asia-specific assays on QuantuMDx's Q-POC™

First test to direct treatment of chronic leukemia and lung cancer.A*STAR’s Genome Institute of Singapore (GIS) has signed an agreement with QuantuMDx (QMDx), a UK-based biotech developing handheld diagnostics and whole genome sequencing devi...

Lifestyle Designer Kathy Ireland & Noted Surgeon and Researcher, Dr. David Scharp To Launch Skin Rejuvenation Product, Stemage, From Stem Cell-Derived Ingredients

LOS ANGELES, May 22, 2013 /PRNewswire/ -- Kathy Ireland, CEO and Chief Designer of kathy ireland Worldwide (kiWW) and leading women's health advocate, and world-renowned board certified surgeon Dr. David Scharp today announced their collaboration in bringing to the beauty market a stem cell-derived product brand named Stemage. They note that the unique aspect of the natural skin rej...

Emory University researchers identify a protein that stimulates orphan receptors in the brain

Researchers at Emory University have identified a protein that stimulates a pair of "orphan receptors" found in the brain, solving a long-standing biological puzzle and possibly leading to future treatments for neurological diseases.

Poliovirus vaccine study shows encouraging results in glioblastoma patients

An attack on glioblastoma brain tumor cells that uses a modified poliovirus is showing encouraging results in an early study to establish the proper dose level, researchers at Duke Cancer Institute report.

"Friendly Viruses" Shield Us From Infection

We have heard of friendly gut bacteria that help us digest food and are thought to be essential for gut development, but now, in a new breakthrough study, scientists in the US suggest we also carry friendly viruses that shield us from infection by d...

[Articles] Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: analysis of baseline data

Preclinical SCA1 and SCA2 mutation carriers seem to have mild coordination deficits and abnormalities in the brain that are more common in carriers who are closer to the estimated onset of ataxia. Individuals in this early disease stage could be targ...

[Comment] Presymptomatic features of spinocerebellar ataxias

Although more than 30 genetically distinct forms of dominant progressive spinocerebellar ataxia (SCA) are now recognised, more than half of all families affected by SCAs have SCA1, SCA2, SCA3, or SCA6. All these forms are characterised by expanded po...

UC researchers identify biomarkers for inflammatory bowel disease

Using the Department of Defense Serum Repository, University of Cincinnati researchers have identified a number of biomarkers for inflammatory bowel disease, which could help with earlier diagnosis and intervention in those who have not yet shown sym...

Agenus Announces Initiation of Enrollment in NCI-Sponsored Randomized Trial of Prophage G-200 Vaccine With Avastin in Treatment of Brain Tumors

LEXINGTON, Mass., May 22, 2013 (GLOBE NEWSWIRE) -- Agenus Inc. (Nasdaq:AGEN) today announced enrollment has started for a large, randomized Phase 2 study of Prophage G-200 (Heat Shock Protein Peptide Complex-96 or HSPPC-96) vaccine in combination with bevacizumab (Avastin®) for treatment of recurrent glioblastoma multiforme (GBM) in adult patients. The study is being sponsored by the Alliance fo...

In The Resurgence Of Whooping Cough, Leading Explanations Don't Stand Up To Scrutiny

Whooping cough has exploded in the United States and some other developed countries in recent decades, and many experts suspect ineffective childhood vaccines for the alarming resurgence. Some say the vaccine wears off quicker than public health offi...

Minicircle DNA is Superior to Plasmid DNA in Eliciting Antigen-specific CD8+ T-cell Responses

Kathy Giusti, Founder and CEO of the Multiple Myeloma Research Foundation (MMRF), Receives Honorary Degree from The University of Vermont (UVM)

Honorary Degree Recognizes her Leadership in Cancer Research The Multiple Myeloma Research Foundation (MMRF) is honored to announce that Kathy Giusti, MMRF Founder and CEO, was presented with an Honorary Doctor of Humane Letters degree from The University of Vermont (UVM) on Sunday, May 19, 2013. UVM celebrated its 211th commencement and presented five...

BIO Issues Call for Paper and Panel Submissions for 2013 Pacific Rim Summit on Industrial Biotech and Bioenergy

The Biotechnology Industry Organization (BIO) invites leaders from the biotechnology, chemical and agricultural industries to submit proposals and abstracts for panels, individual papers and posters for the 2013 Pacific Rim Summit on Industrial Biotechnology and Bioenergy. This unique conference will be held Dec. 8-11, 2013 in San Diego. Participa...

Human medicines European Public Assessment Report (EPAR): Prepandrix, prepandemic influenza vaccine (H5N1) (split virion, inactivated, adjuvanted), Revision: 7, Authorised